Low-dose Naltrexone for Post-COVID Fatigue Syndrome

Clinical trial NCT05430152 · COMPLETED

Trial details

NCT number: NCT05430152
Sponsor: Luis Nacul
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Post-Viral Fatigue Syndrome

Start date: 2024-01-15
Primary completion: 2026-02-15
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.